Androgen Receptor and Non-Coding RNAs’ Interaction in Renal Cell Carcinoma
Renal cell carcinoma (RCC), the most prevalent among the urogenital cancers, accounts for around 3% of new cancer cases worldwide. Significantly, the incidence of RCC has doubled in developed world countries, ranking it as the sixth most common cancer in males, who represent two-thirds of RCC cases....
Saved in:
Main Authors: | Manal A. Hussain, Noha M. Elemam, Iman M. Talaat |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-11-01
|
Series: | Non-Coding RNA |
Subjects: | |
Online Access: | https://www.mdpi.com/2311-553X/10/6/56 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Perspectives on Prostate Cancer: The Role of microRNAs in Androgen Receptor Regulation
by: Asbiel Felipe Garibaldi-Ríos, et al.
Published: (2024-11-01) -
The oncogenic lncRNA MIR503HG suppresses cellular senescence counteracting supraphysiological androgen treatment in prostate cancer
by: Julia Kallenbach, et al.
Published: (2024-12-01) -
Identification of hub genes, non-coding RNAs and pathways in Renal cell carcinoma (RCC): A comprehensive in silico study
by: Ahmad Golestanifar, et al.
Published: (2025-03-01) -
Molecular mechanism of androgen receptor mutation in multigenerational mild androgen insensitivity syndrome
by: Ravind Pandher, et al.
Published: (2024-12-01) -
Cardiomyopathies: The Role of Non-Coding RNAs
by: Nicole Carabetta, et al.
Published: (2024-10-01)